Sarah A Holstein

29PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Instrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 31, 2025
Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development.

Staci L Haney, Sarah A Holstein

|Aug 28, 2025
The role of the unfolded protein response pathway in bone homeostasis and potential therapeutic target in cancer-associated bone disease.

Molly E Muehlebach, Sarah A Holstein

|Apr 25, 2025
A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma.

Sarah A Holstein, Shebli Atrash, Hira Mian

|Dec 19, 2024
Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity.

Molly E Muehlebach, Staci L Haney, Yashpal S Chhonker

|Dec 04, 2024
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma.

Dan T Vogl, Shebli Atrash, Sarah A Holstein

|Sep 28, 2024
Development and Validation of an LC-MS/MS Assay for the Quantitation of MO-OH-Nap Tropolone in Mouse Plasma: Application to In Vitro and In Vivo Pharmacokinetic Studies.

Wafaa N Aldhafiri, Yashpal S Chhonker, Nusrat Ahmed

Pageof 5

Frequent Collaborators

4 joint publications

Jonathan L Kaufman

3 joint publications

Luciano J Costa

3 joint publications

Larry D Anderson

3 joint publications

Brandi Reeves